Study flowchart of the study population selection.

Study flowchart of the study population selection.

<p>AMI, acute myocardial infarction; KAMIR-NIH, Korea Acute Myocardial Infarction Registry-National Institutes of Health; KAMIR-V, Korea Acute Myocardial Infarction Registry-V.</p>

Saved in:

Bibliographic Details
Main Author:	Seok Oh (12176510) (author)
Other Authors:	Kyung Hoon Cho (12176516) (author), Min Chul Kim (267630) (author), Doo Sun Sim (12176519) (author), Young Joon Hong (2104192) (author), Ju Han Kim (10092) (author), Youngkeun Ahn (564628) (author), Sang Yeub Lee (4922758) (author), Min-Ho Shin (582888) (author), Weon Kim (836731) (author), Myung Ho Jeong (8201055) (author)
Published:	2024
Subjects:	Pharmacology Biotechnology Marine Biology Science Policy Computational Biology density lipoprotein cholesterol ezetimibe use increased ezetimibe prescription rates lipid management guidelines year temporal trends lipid management trends important risk factor dl (& lt acute myocardial infarction 2011 &# 8211 1 %, whereas xlink "> dyslipidemia dyslipidemia prevalence increased c target reduction american target ), lipid management year trends xlink "> myocardial infarction increased gradually dyslipidemia prevalence l ), achievement rates c target world data study used study aimed primary endpoints merged database korean patients intensity statin included 26 continued efforts clinical practice c targets 751 participants 70 mg
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Baseline characteristics of the participants in the study cohort.
by: Seok Oh (12176510)
Published: (2024)

Temporal trends in lipid management in the study cohort.
by: Seok Oh (12176510)
Published: (2024)

Temporal trends in dyslipidemia prevalence and medication prescriptions in the study cohort.
by: Seok Oh (12176510)
Published: (2024)

Associations between statin strategies and the incidence of LDL-C target goal attainment according to each Cox model.
by: Seok Oh (12176510)
Published: (2024)

Proportions of prescriptions of post-discharge medications and PCI utilization according to Killip functional class, serum creatinine levels, and LVEF.
by: Seok Oh (12176510)
Published: (2024)

Temporal trends in the attainment rates of LDL-C targets.
by: Seok Oh (12176510)
Published: (2024)

Temporal trends in LDL-C levels during index hospitalization (at baseline) and at 1 year after AMI.
by: Seok Oh (12176510)
Published: (2024)

Temporal trends in the prescription fill rates of non-statin lipid-lowering agents.
by: Seok Oh (12176510)
Published: (2024)

Temporal trends in the prescription fill rates of statins.
by: Seok Oh (12176510)
Published: (2024)

Temporal trends in the prevalence of dyslipidemia.
by: Seok Oh (12176510)
Published: (2024)

Additional file 4 of Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention
by: Eun Ho Choo (5503682)
Published: (2024)

Additional file 3 of Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention
by: Eun Ho Choo (5503682)
Published: (2024)

Additional file 2 of Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention
by: Eun Ho Choo (5503682)
Published: (2024)

Data Sheet 1_Suboptimal management of hypercholesterolemia in countries with high or very high cardiovascular risk: findings from the international DISCOVERY study.pdf
by: Mišo Šabović (22188742)
Published: (2025)

Ezetimibe and the risk of new-onset type 2 diabetes: a systematic review and meta-analysis
by: Areej S. Albawa’neh (22749941)
Published: (2025)

Characteristics of study participants.
by: Ruth Ayanful-Torgby (3418706)
Published: (2025)

Supplementary materials: Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy
by: David Garcia (13102243)
Published: (2025)

Lipid profile and comparison across age groups.
by: Ruth Ayanful-Torgby (3418706)
Published: (2025)

Comparison frequency of altered lipid parameters between age groups/sex.
by: Ruth Ayanful-Torgby (3418706)
Published: (2025)

Data Sheet 1_Molecular and clinical profiles of T2DM, dyslipidemia, and periodontitis: insights into inflammatory and metabolic dysregulation.csv
by: Peace Ngozi Okoro (21383036)
Published: (2025)

Data Sheet 3_Molecular and clinical profiles of T2DM, dyslipidemia, and periodontitis: insights into inflammatory and metabolic dysregulation.csv
by: Peace Ngozi Okoro (21383036)
Published: (2025)

Data Sheet 2_Molecular and clinical profiles of T2DM, dyslipidemia, and periodontitis: insights into inflammatory and metabolic dysregulation.csv
by: Peace Ngozi Okoro (21383036)
Published: (2025)

Data Sheet 4_Molecular and clinical profiles of T2DM, dyslipidemia, and periodontitis: insights into inflammatory and metabolic dysregulation.csv
by: Peace Ngozi Okoro (21383036)
Published: (2025)

Data Sheet 5_Molecular and clinical profiles of T2DM, dyslipidemia, and periodontitis: insights into inflammatory and metabolic dysregulation.csv
by: Peace Ngozi Okoro (21383036)
Published: (2025)

The study workflow.
by: Yanan Wang (123548)
Published: (2024)

Table 1_Impact of comorbid burden on global left cardiac function and prediction models for myocardial function damage: a cardiac magnetic resonance feature-tracking study.docx
by: XiaoFeng Qu (20718092)
Published: (2025)

<b>Lipidomic signatures of insulin resistance in Asian male subjects identified from hyperinsulinemic-euglycemic clamp studies</b>
by: Sartaj Ahmad Mir (21580749)
Published: (2025)

Data Sheet 1_A retrospective study on LDL-C goal attainment in readmitted hypertriglyceridemia patients: risk factor analysis.csv
by: Yuan Ji (5702)
Published: (2025)

Table 1_Lipid abnormality in diabetic kidney disease and potential treatment advancements.docx
by: Qian Ming Tu (20892596)
Published: (2025)

Data Sheet 1_Evaluating the effect of mobile applications “My A:Care” and “Smart Coach” on adherence to lipid-lowering treatment in patients with dyslipidemia: a prospective, randomized, open-label clinical study.docx
by: Chatlert Pongchaiyakul (5465432)
Published: (2025)

Data Sheet 1_Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia: evidence from CHARLS.pdf
by: Changbo Sun (19229897)
Published: (2025)

Table 1_Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia: evidence from CHARLS.docx
by: Changbo Sun (19229897)
Published: (2025)

Table 2_Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia: evidence from CHARLS.docx
by: Changbo Sun (19229897)
Published: (2025)

Data Sheet 2_Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia: evidence from CHARLS.pdf
by: Changbo Sun (19229897)
Published: (2025)

Familial hypercholesterolemia in paediatric patients with type 1 diabetes - Double challenge for diagnosis and treatment.
by: Marianne Becker (22310618)
Published: (2025)

Association of two initial HAART regimens with different lipid types.
by: Yanan Wang (123548)
Published: (2024)

Basic characteristics of participants.
by: Yanan Wang (123548)
Published: (2024)

Prevalence of dyslipidemia by subpopulation.
by: Yanan Wang (123548)
Published: (2024)

Changes in the prevalence of dyslipidemia in PLHIV receiving different HAART regimens.
by: Yanan Wang (123548)
Published: (2024)

Repeat measurements of blood lipids in PLHIV receiving different HAART regimens.
by: Yanan Wang (123548)
Published: (2024)

Cannot write session to /tmp/vufind_sessions/sess_gf8353j59g4fupfs1u9uq5nvr0